| Carl W. Langren |
Carl W. Langren occupies the position of Secretary, Chief Financial & Accounting Officer at NewLink Genetics Corp.
In the past Mr. Langren held the position of Chief Financial Officer at Housby Mixer Group LLC, Principal at Capital Management Solutions LLC, Tax Manager at RSM US LLP, President for Iowa Machinery & Supply Co., Inc., Chief Financial Officer for Equity Dynamics, Inc., Chief Financial Officer of BioProtection Systems Corp. and Treasurer at DFM Corp.
He received an undergraduate degree from the University of Iowa. |
| Eugene P. Kennedy |
Currently, Eugene P. Kennedy is Chief Medical Officer for NewLink Genetics Corp.
In his past career Dr. Kennedy occupied the position of Associate Professor-Surgery at Thomas Jefferson University.
He received an undergraduate degree from the University of Virginia and a doctorate from Medical College of Virginia. |
| Ernest Joseph Talarico |
Mr. Ernest J. Talarico, III, is a Senior Managing Director at Mesirow Financial Investment Management, Inc. Mr. Talarico is also a relationship manager and investment committee member in Mesirow Financial's Retirement Planning and Advisory group. He helps qualified retirement plan sponsors effectively establish and maintain their fiduciary process. Mr. Talarico also works with high net worth individuals, business owners and not-for profit entities to create comprehensive wealth management strategies. He joined Mesirow Financial in 1998. Mr. Talarico is also a member of the firm's select advisory board, which is responsible for performing due diligence on external money managers. He serves on the board of directors for NewLink Genetics, a biotech company located in Ames, Iowa.
He earned a BA from the University of Iowa and is an Accredited Investment Fiduciary (AIF). |
| Lota S. Zoth |
Presently, Lota S. Zoth holds the position of Chairman for Zymeworks, Inc. Ms. Zoth is also on the board of NewLink Genetics Corp. and Inovio Pharmaceuticals, Inc.
In the past Ms. Zoth held the position of Chief Financial Officer & Senior Vice President at Medimmune, Inc., Vice President-Finance at Marriott International, Inc., Chief Accounting Officer & Controller of PepsiCo, Inc., Chairman of Orexigen Therapeutics, Inc., Chief Financial Officer & Senior Vice President of MedImmune LLC, Auditor at Ernst & Young LLP (Missouri), Chief Accounting Officer, VP & Controller for Sodexho Marriott Services, Inc. and Senior Vice President & Controller at PSINet, Inc.
She received an undergraduate degree from Texas Tech University. |
| Chad A. Johnson |
Chad A. Johnson occupies the position of General Counsel of Stine Seed Co. Mr. Johnson is also on the board of NewLink Genetics Corp.
In his past career he occupied the position of Senior Corporate Counsel & Assistant Secretary at Renewable Energy Group, Inc.
Mr. Johnson received a graduate degree from Iowa State University and a graduate degree from Drake University Law School. |
